Breast Cancer Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
Featured
At the annual Miami Breast Cancer Conference, Kelly Hunt, MD, discussed the use of neoadjuvant endocrine therapy for patients with breast cancer.
View More
Anees Chagpar, MD, discusses her presentation on neoadjuvant chemo for clinically node-negative (cN0) breast cancer that took place at the annual Miami Breast Cancer Conference.
View More
Dr Hurvitz discusses the HER2CLIMB and HER2CLIMB-02 trials examining tucatinib's activity and safety in patients with HER2-positive metastatic breast cancer.
View More
Mattea Reinisch, MD, highlights the final efficacy and safety results of the phase 3b, multi-center, open-label Ribecca trial for women with ER+, HER2- locally advanced or metastatic breast cancer,…
View More
Dr Linden shares encouraging results from the AMEERA-1 trial of SAR439859 for ER+/HER2- metastatic breast cancer, presented at the virtual 2020 SABCS Annual Meeting.
View More
"HDRT allows precise control over the delivered amount of radiation and limits the exposure of surrounding healthy tissue," explains Alison Calkins, MD, in this breast cancer commentary.
View More
Alison Calkins, MD, discusses the use of partial breast radiation therapy (breast brachytherapy) for patients with local breast cancer.
View More
Hope S. Rugo, MD, discusses the OS findings of 2 trials examining ribociclib plus endocrine therapy for advanced breast cancer and visceral metastases.
View More
Julie Gralow, MD, discusses the findings of the phase 2 SWOG S1416 trial.
View More
Stay in the know.
OncNet Newsletter